First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Axitinib continuous oral dosing (10 mg once a day, 10 mg twice a day, 20 mg twice a day or 30 mg twice day) in the fed state

Axitinib continuous oral dosing (20 mg twice a day) in the fed state

Axitinib continuous oral dosing (5 mg twice a day) in the fed state

Axitinib continuous oral dosing (15 mg once a day) in the fed state

Axitinib continuous oral dosing (5 mg twice a day) in the fasted state

Axitinib continuous oral dosing (2 mg twice a day on the first day of dosing, followed by 5 mg twice a day) in the fasted state